2022
DOI: 10.1053/j.semnuclmed.2021.11.014
|View full text |Cite
|
Sign up to set email alerts
|

PET/MR Technology: Advancement and Challenges

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 148 publications
0
6
0
Order By: Relevance
“…6a). Given the tremendous technological efforts made for the development of multimodal scanner [142] and multimodal probes [143] to simultaneously acquire PET and MRI signals, a middle term blue-sky project will most likely consist in evaluating in real time the dynamic interactions between CNS resident microglia and peripheral macrophages, or between microglia and autoreactive B or T cells in NHP models of MS [136]. On top of providing fundamental knowledge on the neuroinflammatory cascades regulating human health, this same technology will undoubtedly prove useful to optimize pharmacological treatments delivery [144] or to track the distribution of myelin specific chimeric antigen receptor T cells (CAR-T) either injected systemically [145] or generated in vivo through viral therapy [146].…”
Section: Multimodality For Complete Investigation Of Nhp Models and C...mentioning
confidence: 99%
“…6a). Given the tremendous technological efforts made for the development of multimodal scanner [142] and multimodal probes [143] to simultaneously acquire PET and MRI signals, a middle term blue-sky project will most likely consist in evaluating in real time the dynamic interactions between CNS resident microglia and peripheral macrophages, or between microglia and autoreactive B or T cells in NHP models of MS [136]. On top of providing fundamental knowledge on the neuroinflammatory cascades regulating human health, this same technology will undoubtedly prove useful to optimize pharmacological treatments delivery [144] or to track the distribution of myelin specific chimeric antigen receptor T cells (CAR-T) either injected systemically [145] or generated in vivo through viral therapy [146].…”
Section: Multimodality For Complete Investigation Of Nhp Models and C...mentioning
confidence: 99%
“…Compared with PET-CT, PET-MRI offers superior soft tissue contrast, which is excellent for the detection of primary tumors and metastases in soft tissues, and provides a more accurate staging of tumors [79]. In detecting CRC-PM, PET-MRI exhibits similar performance to PET-CT but with higher specificity [80]. However, it is worth noting that although PET-MRI is advantageous in monitoring tumor recurrence, its comprehensive use in clinical practice is hindered by the high radiation dose and examination cost associated with the technology.…”
Section: Pet-mrimentioning
confidence: 99%
“…74 Nevertheless, none of the proposed metal artifact reduction methods have provided reliable and robust image reconstruction in the context of clinical PET/MR imaging, and as such, this issue warrants further investigation. 3…”
Section: Metal Artefact Reduction Techniquesmentioning
confidence: 99%
“…1,2 In contrast to the widespread adoption of hybrid PET/CT scanners in the clinical setting, PET/MR imaging couldn't reach many sites and may bear only 5% of the total PET market. 3 This trend could be attributed to the high cost and new paradigms introduced by this technology, workflow, and logistics issues, and the challenges associated with quantitative PET/MR imaging. Since the introduction of PET/MRI systems, substantial efforts have been made to find/establish the key clinical applications of this modality in order to justify/promote its utilization.…”
Section: Introductionmentioning
confidence: 99%